Division of Infectious Diseases and International Health, University of Virginia, PO Box 801379, Carter Harrison Research Bldg MR-6, 345 Crispell Drive, Room 2520, Charlottesville, Virginia 22908-1379, United States of America (USA).
Fogarty International Center, National Institutes of Health, Bethesda, USA .
Bull World Health Organ. 2017 Jan 1;95(1):49-61. doi: 10.2471/BLT.16.176123. Epub 2016 Nov 3.
To describe the frequency and factors associated with antibiotic use in early childhood, and estimate the proportion of diarrhoea and respiratory illnesses episodes treated with antibiotics.
Between 2009 and 2014, we followed 2134 children from eight sites in Bangladesh, Brazil, India, Nepal, Pakistan, Peru, South Africa and the United Republic of Tanzania, enrolled in the MAL-ED birth cohort study. We documented all antibiotic use from mothers' reports at twice-weekly visits over the children's first two years of life. We estimated the incidence of antibiotic use and the associations of antibiotic use with child and household characteristics. We described treatment patterns for diarrhoea and respiratory illnesses, and identified factors associated with treatment and antibiotic class.
Over 1 346 388 total days of observation, 16 913 courses of antibiotics were recorded (an incidence of 4.9 courses per child per year), with the highest use in South Asia. Antibiotic treatment was given for 375/499 (75.2%) episodes of bloody diarrhoea and for 4274/9661 (44.2%) episodes of diarrhoea without bloody stools. Antibiotics were used in 2384/3943 (60.5%) episodes of fieldworker-confirmed acute lower respiratory tract illness as well as in 6608/16742 (39.5%) episodes of upper respiratory illness. Penicillins were used most frequently for respiratory illness, while antibiotic classes for diarrhoea treatment varied within and between sites.
Repeated antibiotic exposure was common early in life, and treatment of non-bloody diarrhoea and non-specific respiratory illnesses was not consistent with international recommendations. Rational antibiotic use programmes may have the most impact in South Asia, where antibiotic use was highest.
描述儿童早期抗生素使用的频率和相关因素,并估计用抗生素治疗腹泻和呼吸道疾病的比例。
2009 年至 2014 年,我们在孟加拉国、巴西、印度、尼泊尔、巴基斯坦、秘鲁、南非和坦桑尼亚联合共和国的 8 个地点,对 2134 名参加 MAL-ED 出生队列研究的儿童进行了随访。我们通过母亲在儿童生命的头两年每两周一次的就诊时的报告,记录了所有的抗生素使用情况。我们估计了抗生素使用的发生率,并分析了抗生素使用与儿童和家庭特征的关系。我们描述了腹泻和呼吸道疾病的治疗模式,并确定了与治疗和抗生素类别相关的因素。
在 1 346 388 总观察日中,记录了 16 913 例抗生素疗程(每个儿童每年 4.9 例),南亚的使用率最高。抗生素治疗用于 499 例血性腹泻中有 375 例(75.2%),9661 例非血性腹泻中有 4274 例(44.2%)。在 3943 例经现场工作人员确诊的急性下呼吸道疾病中有 2384 例(60.5%),在 16742 例上呼吸道疾病中有 6608 例(39.5%)使用了抗生素。青霉素最常用于治疗呼吸道疾病,而腹泻治疗的抗生素类别在不同地点之间存在差异。
儿童生命早期反复暴露于抗生素很常见,非血性腹泻和非特异性呼吸道疾病的治疗不符合国际建议。在抗生素使用最高的南亚地区,合理使用抗生素方案可能会产生最大的影响。